Aaron Tward
About Aaron Tward
Aaron Tward is the Chief Scientific Officer at Affinia Therapeutics, an Associate Professor at UCSF, and a co-founder of Affinia Therapeutics, with expertise in genomics, cancer biology, and skull base surgery.
Chief Scientific Officer: Aaron Tward
Aaron Tward serves as the Chief Scientific Officer. He oversees the scientific direction and strategy of the organization, ensuring alignment with broader research and clinical goals. His role focuses on fostering innovative research to advance medical and scientific knowledge.
Aaron Tward's Education and Expertise
Aaron Tward holds a Ph.D. in biomedical sciences and an M.D. from the University of California, San Francisco (UCSF). He completed his residency in otolaryngology-head and neck surgery, followed by a fellowship in otology, neurotology, and skull base surgery at Harvard Medical School. His advanced training continued with a post-doctoral fellowship at the Broad Institute of MIT and Harvard, emphasizing his deep expertise in both clinical and research domains.
Aaron Tward's Background in Medical Training
Aaron Tward completed rigorous medical training that includes a residency in otolaryngology-head and neck surgery and a fellowship specializing in otology, neurotology, and skull base surgery at Harvard Medical School. These qualifications underpin his comprehensive knowledge in head and neck surgical practices and advanced medical procedures.
Aaron Tward's Co-Founder Role at Affinia Therapeutics
Aaron Tward is a co-founder of Affinia Therapeutics, contributing to its establishment and development. Affinia Therapeutics focuses on enhancing gene therapies through targeted innovation. His role in the inception of the company highlights his entrepreneurial spirit and commitment to advancing therapeutic solutions.
Aaron Tward's Academic Contributions
Aaron Tward has made significant academic contributions, authoring more than 30 publications in areas such as genomics, cancer biology, stem cell biology, and skull base surgery. His work has added to the scientific community's understanding of these fields. He also serves as an Associate Professor at UCSF, where he is involved in educating future medical and research professionals.